BriaCell’s BriaPro Files Patent for TILsRx Immuno-Oncology Platform Featuring Multitargeting, Multivalent Agents
Read Press Release for Briacell Therapeutics Corp. – Warrant (BCTXW) published on Jul. 29, 2025 – BriaCell’s Subsidiary, BriaPro, Files Patent
Continue Reading